GURU.Markets stock price, segment price, and overall market index valuation
The company's share price PODD
Insulet revolutionized diabetes treatment with its Omnipod tubeless insulin pump. The company's stock chart tells the story of the rapid adoption of a new technology that makes life easier and more convenient for people with diabetes.
Share prices of companies in the market segment - Specialized medical equipment
Insulet revolutionized diabetes treatment with its Omnipod tubeless insulin pump. We classify it as a Specialized Medical Equipment product. The chart below shows the overall dynamics of this rapidly growing market, where technology is changing the standard of care.
Broad Market Index - GURU.Markets
Insulet is a medical company that developed the innovative Omnipod insulin delivery system, a tubeless pump. It is a component of the GURU.Markets index. The chart below represents the market. See how diabetes treatment technologies are impacting Insulet stock.
Change in the price of a company, segment, and market as a whole per day
PODD - Daily change in the company's share price PODD
Insulet is a medical device company that developed the innovative Omnipod tubeless insulin delivery system. Its daily share price reflects its high volatility and sensitivity to news in the diabetes treatment sector. This metric is a key component in the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
Insulet Corporation is an innovator in the insulin pump market. This chart shows the average daily volatility of the medical device sector. Comparing it to PODD, whose growth depends on the adoption of its tubeless technology, helps assess its market prospects.
Daily change in the price of a broad market stock, index - GURU.Markets
Insulet is the maker of the innovative Omnipod tubeless insulin delivery system. The diabetes medical device market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how Insulet shares are responding to innovation and competition.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization PODD
Insulet is a revolutionary company that produces Omnipod tubeless insulin pumps. Its year-over-year growth reflects the rapid growth of this technology, which is changing the lives of millions of people with diabetes. The chart below tells the story of this dominance.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
Insulet Corporation has revolutionized diabetes treatment with its Omnipod tubeless insulin pump. Its innovative product and subscription model are fueling rapid growth. This chart shows how its technology and focus on patient convenience are helping it gain market share from traditional pumps.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Insulet Corporation is the manufacturer of innovative Omnipod tubeless insulin pumps, which are changing the lives of people with diabetes. The company's growth is driven by the widespread adoption of its convenient technology. Insulet's stock price reflects this powerful, long-term trend in medical technology, independent of the economic climate.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization PODD
The value of Insulet Corporation, the maker of Omnipod insulin pumps, reflects the pace of adoption of its tubeless technology. Monthly fluctuations on the chart depend on the growth of new users and expanded access to its product through insurance companies, which is a key driver of its operational growth.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
Insulet Corporation revolutionized diabetes treatment with its Omnipod tubeless insulin pump. The dynamics of the specialized medical equipment sector, shown in the graph, reflect the speed of adoption of new technologies. Against this backdrop, it's interesting to examine how Insulet's innovative product and its subscription model impacted the company's growth compared to overall industry trends.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Shares of medical device makers treating chronic diseases like diabetes combine stable demand with high growth potential. The chart below shows overall market sentiment. What influences Insulet Corporation more: the defensive nature of the medical industry or the volatility of growth stocks?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization PODD
Insulet Corporation, a developer of innovative insulin delivery systems (OmniPods), whose weekly stock price reflects competition and innovation in the diabetes treatment market. News of new product approvals, user growth data, and competitor actions shape short-term trends.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
Insulet, a manufacturer of insulin pumps, often sets trends in its medical device segment. This chart compares the company's performance with the broader sector, demonstrating how its innovation and growth allow it to outpace the industry even when overall sentiment in the healthcare sector is muted.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Insulet Corporation produces Omnipod insulin pumps. The company's growth is driven by medical needs and innovations in diabetes treatment. The chart shows how Insulet's stock price is unaffected by overall market fluctuations, riding the wave of its technology adoption.
Market capitalization of the company, segment and market as a whole
PODD - Market capitalization of the company PODD
Insulet Corporation's market capitalization is a financial story of needle-free diabetes. The Omnipod, the manufacturer of tubeless insulin pumps, reflects investors' belief that the simplicity and convenience of its technology will conquer the market. Its growth reflects a bet on innovations that dramatically improve patients' quality of life.
PODD - Share of the company's market capitalization PODD within the market segment - Specialized medical equipment
Insulet Corporation is the maker of the innovative Omnipod insulin delivery system, which operates without tubing. Its market share in the diabetes medical equipment sector reflects the popularity of its unique product. The chart below shows how the company is gaining market share from traditional insulin pumps.
Market capitalization of the market segment - Specialized medical equipment
Insulet is the manufacturer of the innovative Omnipod tubeless insulin pump. The chart below shows the overall market capitalization of the entire diabetes medical technology sector. Its rapid growth reflects the demand for more convenient and effective ways to manage the disease.
Market capitalization of all companies included in a broad market index - GURU.Markets
Insulet changed the lives of people with diabetes by creating a tubeless insulin pump. Its market capitalization chart is a history of innovation in medical technology. It shows how a device that gives patients freedom can capture a significant share of the global healthcare market and economy.
Book value capitalization of the company, segment and market as a whole
PODD - Book value capitalization of the company PODD
The book value of Insulet, a manufacturer of insulin pumps, is represented by its production lines and R&D centers. The chart below shows how the company is expanding its resources to produce its innovative medical devices. Its growth is a clear sign of its expansion to help people with diabetes.
PODD - Share of the company's book capitalization PODD within the market segment - Specialized medical equipment
Insulet produces tubeless insulin pumps that change the lives of people with diabetes. Mass production of these high-tech devices requires modern, automated factories. The share price chart shows how the company is expanding its physical production base to meet growing demand.
Market segment balance sheet capitalization - Specialized medical equipment
As the chart shows, medical equipment manufacturing is a capital-intensive industry. Insulet is a prime example. Mass production of its unique insulin pumps requires state-of-the-art automated factories. The company is consciously investing in this physical infrastructure.
Book value of all companies included in the broad market index - GURU.Markets
Insulet revolutionized diabetes treatment with its tubeless insulin pump. The company's assets include automated factories that produce these vital devices. The chart below illustrates the physical scale of the company, which has freed millions of people from daily injections.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - PODD
Insulet Corporation is the manufacturer of Omnipod insulin pumps. Its valuation is enormous, reflecting its unique tubeless technology, rapid growth, and its business model based on recurring pod sales.
Market to book capitalization ratio in a market segment - Specialized medical equipment
Insulet Corporation is the manufacturer of the innovative Omnipod insulin pump. The company's value lies in its unique tubeless technology and patents. This chart shows how its market valuation, reflecting the expected growth in the number of diabetes patients, exceeds its book value by a multiple.
Market to book capitalization ratio for the market as a whole
Insulet Corporation is the manufacturer of the innovative Omnipod insulin delivery system, a tube-free system. This medical technology is changing the lives of people with diabetes. Its core assets are its patents, brand, and recurring revenue model from cartridge sales. The chart demonstrates how highly the market values this growing, high-margin business.
Debts of the company, segment and market as a whole
PODD - Company debts PODD
Insulet, the maker of the innovative Omnipod tubeless insulin pump, is using debt to fund its rapid growth and R&D. The company is actively investing in developing new generations of devices and expanding access to its technology for people with diabetes worldwide. This chart shows how the revolution in diabetes treatment is being funded.
Market segment debts - Specialized medical equipment
Insulet Corporation is the manufacturer of the innovative Omnipod insulin delivery system, which eliminates the need for tubing. The company is experiencing rapid growth, capturing market share from traditional insulin pumps. Its leverage reflects significant investments in marketing and R&D. This chart shows how Insulet is funding its expansion into the diabetes medical technology sector.
Market debt in general
Insulet Corporation is the manufacturer of the innovative Omnipod insulin delivery system. This is a rapidly growing market, where the company competes with medical technology giants. The overall debt situation in the market reflects the climate in which Insulet is raising funds to finance R&D, marketing, and expanding production capacity to meet growing demand.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio PODD
Insulet, a manufacturer of innovative insulin pumps, is experiencing rapid growth, capturing market share from traditional diabetes treatments. This chart shows how the company is funding its expansion and R&D. Debt can be a sign of confidence in future demand, but it can also be a risk factor in the competitive medical device market.
Market segment debt to market segment book capitalization - Specialized medical equipment
Insulet Corporation revolutionized diabetes treatment with its Omnipod tubeless insulin pump. This chart shows the debt burden in the specialized medical device sector. It helps understand how companies in this innovative niche finance their research, development, and the launch of life-changing products.
Debt to book value of all companies in the market
Insulet, the creator of a tubeless insulin pump, operates in the fast-growing medical device sector. This chart shows the overall market leverage. It allows one to compare the financial model of an innovative company requiring capital investment with the more conservative capital structure of mature companies in the economy.
P/E of the company, segment and market as a whole
P/E - PODD
This metric for Insulet Corporation, the creator of the innovative Omnipod insulin delivery system, reflects the high valuation of its tubeless technology. The company is transforming the lives of people with diabetes. The high value on the chart indicates investors are betting on rapid growth and the displacement of traditional insulin pumps, rather than focusing on current profitability.
P/E of the market segment - Specialized medical equipment
Insulet Corporation develops and manufactures innovative tubeless insulin delivery systems under the Omnipod brand. The company's devices make life easier for people with diabetes. This chart illustrates the average valuation in the specialized medical equipment sector, where investors highly value technologies that improve patients' quality of life and create new markets.
P/E of the market as a whole
Insulet Corporation revolutionized diabetes treatment with its Omnipod tubeless insulin pump. The company's growth is driven by patient adoption of more convenient technology. This chart shows overall market sentiment. Comparisons with it demonstrate how Insulet's valuation represents a unique medical breakthrough, independent of overall economic trends.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company PODD
Insulet Corporation produces the innovative Omnipod insulin delivery system, a tubeless insulin pump. This chart shows market expectations for the future of diabetes treatment. The valuation is heavily dependent on the adoption of its technology by patients and physicians, expanding insurance coverage, and competition in the diabetes device market.
%20P%2FE%20PODD&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-PODD&v=1772511645365 "Chart of the company's future (projected) P/E PODD")
Future (projected) P/E of the market segment - Specialized medical equipment
Insulet Corporation develops and manufactures Omnipod tubeless insulin pumps for people with diabetes. This chart compares the company's future profitability expectations with those of the medical device industry. It reflects market confidence that their convenient and innovative technology will enable them to capture a significant share of the insulin pump market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Specialized-medical-equipment&v=1772511645374 "Future (projected) P/E graph of the market segment - Specialized medical equipment")
Future (projected) P/E of the market as a whole
Insulet Corporation developed the innovative Omnipod insulin delivery system, which is changing the lives of people with diabetes. The company's growth is driven by technological advantages and market penetration. This graph of overall market expectations influences Insulet's valuation. Investors are willing to pay a premium for breakthrough medical technologies.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772511645405 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit PODD
Insulet Corporation produces the innovative Omnipod tubeless insulin pump for people with diabetes. This device simplifies diabetes management. The company's profits are growing as more patients switch to its convenient system. This chart demonstrates how technological innovations in medicine improve quality of life and create successful businesses.
Profit of companies in the market segment - Specialized medical equipment
Insulet Corporation revolutionized diabetes treatment with its Omnipod tubeless insulin pump. The company's growth is driven by patient adoption of more convenient technologies. This chart illustrates how innovative medical devices can create new markets and generate high profits, changing the financial landscape of the specialized medical equipment sector.
Overall market profit
Insulet Corporation produces innovative Omnipod tubeless insulin pumps that make life easier for people with diabetes. Demand for these medical devices is driven by patient needs and technological advancements, not by the state of the economy. This makes Insulet's business resilient to cycles, as seen in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company PODD
Insulet revolutionized diabetes treatment with its Omnipod system, the first tubeless insulin pump. This graph reflects future revenue expectations, which depend on how quickly patients transition from traditional injections to pump therapy. Expanding access to the technology and entering new markets are key factors in the forecast.
%20profit%20of%20the%20company%20PODD&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-PODD&v=1772511645477 "Graph of future (projected) profit of the company PODD")
Future (predicted) profit of companies in the market segment - Specialized medical equipment
Insulet Corporation produces the innovative Omnipod insulin delivery system, a tubeless insulin pump. This chart shows the revenue forecast for the specialized medical equipment sector. It reflects expectations for growth in the diabetes treatment market and patient adoption of more convenient technologies, which is the main driver for Insulet.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Specialized-medical-equipment&v=1772511645479 "Graph of future (predicted) profits of companies in a market segment - Specialized medical equipment")
Future (predicted) profit of the market as a whole
Insulet Corporation produces innovative Omnipod tubeless insulin pumps. Its growth is driven by patients switching from traditional diabetes treatments to more convenient technologies. Economic cycles, as illustrated here, have a lesser impact on the company, but they can impact the rate of technology adoption and insurance reimbursement policies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772511645482 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - PODD
Insulet Corporation is the maker of the innovative Omnipod insulin pump, which requires no tubing and is worn directly on the body. The company's revenue is growing rapidly thanks to the convenience of its product for people with diabetes. This chart shows how highly investors value its sales, factoring in the continued adoption of its technology.
P/S market segment - Specialized medical equipment
Insulet Corporation revolutionized diabetes treatment with its Omnipod system—a tubeless insulin pump. This is a fast-growing market focused on patient convenience. This chart shows the average revenue estimate for the medical device sector, helping to understand the premium the market pays for its innovative product and Insulet's strong market position.
P/S of the market as a whole
Insulet Corporation has developed and produces the innovative Omnipod insulin delivery system, a tubeless insulin pump. It's changing the lives of people with diabetes. This chart compares the high revenue estimates of the medical technology company with the more down-to-earth figures of companies in traditional sectors.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company PODD
Insulet Corporation is the manufacturer of the innovative Omnipod insulin delivery system, a tubeless insulin pump. Future revenue depends on the adoption of this technology among people with diabetes. This chart reflects market expectations for insulin pump growth and Insulet's dominance.
%20P%2FS%20PODD&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-PODD&v=1772511645501 "The graph of the company's future (projected) P/S PODD")
Future (projected) P/S of the market segment - Specialized medical equipment
Insulet Corporation produces the innovative Omnipod insulin delivery system, a tubeless insulin pump. It is transforming the quality of life for people with diabetes. This chart reflects the market's high revenue expectations, based on rapid patient adoption and expanded access to its technology worldwide.
%20P%2FS%20market%20segment%20graph%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Specialized-medical-equipment&v=1772511645504 "Future (projected) P/S market segment graph - Specialized medical equipment")
Future (projected) P/S of the market as a whole
Insulet Corporation has revolutionized diabetes treatment with its Omnipod tubeless insulin pump. The company's growth is driven by technological superiority and market penetration. The overall optimism evident in the chart creates a favorable environment for investment in medical technology and increases healthcare systems' willingness to pay for innovations that improve patients' lives.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772511645509 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales PODD
Insulet Corporation has developed the innovative Omnipod insulin pump, which is worn on the body and requires no tubing. The company's revenue comes from sales of these devices, which make life easier for people with type 1 diabetes. The graph shows the rapid growth in adoption of this technology by patients seeking more convenient ways to manage their condition.
Sales of companies in the market segment - Specialized medical equipment
Insulet Corporation is an innovative medical device company known for its OmniPod system for tubeless insulin delivery. This device is an alternative to traditional insulin pumps. The company generates revenue from the sale of these disposable "pods." This chart shows the growing market for diabetes treatment technologies, where the convenience and simplicity of the OmniPod are attracting increasing numbers of users.
Overall market sales
Insulet Corporation produces innovative tubeless insulin pumps, the Omnipod. Demand for its products is driven by the growing number of people with diabetes and the shift to more convenient technologies. While this is a medical necessity, the availability and insurance coverage of these expensive systems depend on the overall health of the economy and healthcare system, as reflected in this chart.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company PODD
Insulet Corporation is the manufacturer of the innovative Omnipod insulin delivery system, a tubeless insulin pump. The company's growth is driven by patients switching from traditional injections to pumps. This chart reflects analysts' forecasts for the adoption rate of Omnipod technology and its increased use among people with type 1 and type 2 diabetes.
%20sales%20of%20the%20company%20PODD&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-PODD&v=1772511645527 "Schedule of future (projected) sales of the company PODD")
Future (projected) sales of companies in the market segment - Specialized medical equipment
Insulet Corporation is the manufacturer of the innovative Omnipod insulin pump, which is worn on the body and requires no tubing. This chart shows the outlook for the medical device sector. It demonstrates how Omnipod's unique and convenient technology is enabling Insulet to rapidly capture share of the insulin therapy market, outpacing overall growth rates.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Specialized-medical-equipment&v=1772511645532 "Schedule of future (projected) sales of companies in the market segment - Specialized medical equipment")
Future (projected) sales of the market as a whole
Insulet Corporation, the manufacturer of the Omnipod tubeless insulin pump, sees this chart as a reflection of the state of healthcare systems. Rising overall economic forecasts ensure stable insurance coverage and funding for medical technologies. This makes innovative devices like the Omnipod more accessible to a wider range of diabetes patients.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772511645543 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality PODD
Insulet Corporation is the manufacturer of the innovative Omnipod insulin delivery system, a tubeless insulin pump. Their success is based on the product's convenience for diabetes patients. This chart illustrates how their unique technology and subscription model enable the company to achieve high profitability in the medical device market.
Market segment marginality - Specialized medical equipment
Insulet Corporation is the manufacturer of the innovative Omnipod insulin delivery system, a tubeless insulin pump. This chart shows the company's profitability in the medical device sector. High performance reflects technological leadership, growing market penetration, and the advantage of a consumables subscription model.
Market marginality as a whole
Insulet Corporation is an innovative company that developed the Omnipod tubeless insulin pump. Its growth is fueled by the adoption of its technology among people with diabetes. This growth is driven by clinical benefits and insurance coverage, rather than by the general economic trends reflected in this chart, which is typical for breakthrough medical technologies.
Employees in the company, segment and market as a whole
Number of employees in the company PODD
Insulet Corporation has revolutionized diabetes treatment with its Omnipod tubeless insulin pump. This chart clearly demonstrates the rapid adoption of its product. The continued growth of its production, sales, and customer support staff is a direct result of the high demand from patients adopting this more convenient technology.
Share of the company's employees PODD within the market segment - Specialized medical equipment
Insulet Corporation revolutionized diabetes treatment with its Omnipod tubeless insulin pump. This chart shows the company's market share in the niche field of insulin delivery devices. It's a testament to its innovative leadership and the scale of its efforts to improve the lives of people with diabetes.
Number of employees in the market segment - Specialized medical equipment
Insulet Corporation developed the innovative Omnipod insulin delivery system—the world's first tubeless insulin pump. The chart shows rapid employment growth in the medical device sector. The team expansion reflects the growing adoption of this patient-friendly technology and the company's efforts to expand its presence in the global diabetes market.
Number of employees in the market as a whole
Insulet Corporation produces innovative Omnipod tubeless insulin pumps. Their growth depends on the introduction of new technologies in diabetes treatment. This overall employment chart reflects the number of people with access to good health insurance. Stable coverage with a quality insurance plan is key to enabling patients to upgrade to more convenient and affordable Insulet devices.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company PODD (PODD)
Insulet Corporation revolutionized diabetes treatment with its Omnipod tubeless insulin pump. This chart shows how the market values this breakthrough medical technology. Its high market capitalization per employee suggests the company's value lies in its patents and its product, which significantly improves patients' quality of life.
%20of%20the%20company%20PODD%20(PODD)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-PODD-PODD&v=1772511645576 "Chart of market capitalization per employee (in thousands of dollars) of the company PODD (PODD)")
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Insulet (PODD) is a manufacturer of tubeless insulin pumps (Omnipod). It's a fast-growing MedTech business with a sticky, razor-sharp model (users constantly buy new pods). This chart shows a high market value per employee, reflecting this high-margin model.
%20by%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Specialized-medical-equipment&v=1772511645583 "Market capitalization per employee (in thousands of dollars) by market segment - Specialized medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Insulet Corporation is the manufacturer of the innovative Omnipod insulin delivery system, which eliminates the need for tubes. The company's value lies in its unique and patient-friendly technology. This chart shows the high market value per employee, reflecting the potential of their product to transform the diabetes treatment market and improve people's quality of life.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772511645586 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company PODD (PODD)
Insulet Corporation produces Omnipod insulin pumps, a tubeless system for people with diabetes. This is a rapidly growing segment of medical technology. This chart shows how effectively the company is scaling production of its innovative product. It reflects how much profit each employee brings in, from R&D to the assembly line, as the number of users of their pumps grows.
%20Chart%20PODD%20(PODD)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-PODD-PODD&v=1772511645588 "Company Profit Per Employee (in thousands of dollars) Chart PODD (PODD)")
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Insulet (PODD) is a medical technology company that produces a tubeless insulin pump (Omnipod). This chart shows the benchmark for "specialized medical equipment." In this sector, R&D is key. The average profit per employee reflects the balance between R&D and high-margin sales of consumables (each Omnipod pump).
%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Specialized-medical-equipment&v=1772511645592 "Chart of profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Insulet Corporation is the manufacturer of the innovative Omnipod insulin delivery system, which eliminates the need for tubes. It is a high-tech medical product that improves patients' quality of life. This chart illustrates how a company that has created a unique and in-demand product can generate high profits thanks to its technological advantage in the medical industry.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772511645595 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee PODD (PODD)
Insulet Corporation is the manufacturer of the innovative OmniPod system, a tubeless insulin pump for people with diabetes. This chart illustrates the performance of the medical technology sector. The growth in revenue per employee reflects the increasing market penetration of their product, automation of production, and the transition to a subscription model, which makes life easier for patients.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-PODD-PODD&v=1772511645600 "Sales chart per company employee PODD (PODD)")
Sales per employee in the market segment - Specialized medical equipment
Insulet is the manufacturer of an innovative tubeless insulin pump (Omnipod). Their business encompasses R&D, production, and a "razor and blades" model (starter pump + regular pods). This chart shows the industry average per employee revenue. It helps assess the viability of this model in the medical niche.
Sales per employee for the market as a whole
Insulet Corporation is the maker of the innovative Omnipod insulin pump. It's a tubeless system (called a "patch pump") that's changing the lives of people with diabetes. It's a medical device with a subscription model (based on "pods"). This chart shows how their team generates high recurring revenue from these high-tech consumables.
Short shares by company, segment and market as a whole
Shares shorted by company PODD (PODD)
Insulet Corporation is the manufacturer of an innovative insulin delivery system (Omnipod), a tubeless pump for people with diabetes. This chart shows bearish sentiment. The shorts could be due to two factors: intense competition from Tandem and Medtronic, and concerns that new weight-loss drugs (GLP-1) will reduce the number of patients requiring intensive insulin therapy.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-PODD-PODD&v=1772511645613 "Short Shares Chart for the Company PODD (PODD)")
Shares shorted by market segment - Specialized medical equipment
Insulet (PODD) is the maker of the innovative Omnipod insulin pump, which requires no tubing and is controlled via smartphone. This chart shows bets against the medical device sector. Rising bets against the industry may signal investor concerns about increased competition (for example, from DexCom/Tandem) or pressure from insurance companies on device prices.
Shares shorted by the overall market
Insulet produces innovative insulin pumps (Omnipod), making life easier for people with diabetes. It's a fast-growing medical sector. However, this chart highlights the general level of fear. When the market panics, even fast-growing medtech companies can be sold off as investors lock in profits in expensive growth stocks.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator PODD (PODD)
Insulet is the creator of the Omnipod, the world's only tubeless insulin pump. It's a growth story in medtech. This oscillator measures the strength of a trend. A quarterly report showing accelerating growth in new patients (new "subscribers" to their pumps) could trigger a powerful rally that could easily push the indicator into overbought territory (above 70).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-PODD-PODD&v=1772511645623 "RSI 14 indicator chart for the company's stock PODD (PODD)")
RSI 14 Market Segment - Specialized medical equipment
Insulet Corporation is a medical device manufacturer known for its innovative Omnipod tubeless insulin pump. This system simplifies diabetes management for patients. This metric measures the overall momentum of the diabetes technology sector. It helps determine whether the entire segment is overheated due to the introduction of new devices or competitive news.
RSI 14 for the overall market
Insulet (PODD) is an innovative healthcare company known for its Omnipod system, a wearable insulin pump for people with diabetes. It's a fast-growing sector of medtech. This indicator measures overall market euphoria. Growth stocks like PODD often overheat during periods of optimism. During periods of panic, investors may overestimate their high valuations.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast PODD (PODD)
Insulet is the maker of the innovative Omnipod insulin pump, which requires no tubing and is controlled via smartphone. This chart shows analysts' assessments of the pace of diabetes' transition from traditional pens to pumps, as well as Insulet's ability to compete with other CGM and pump manufacturers in the rapidly growing market.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-PODD-PODD&v=1772511645636 "A chart showing analyst consensus forecasts for the expected stock price. PODD (PODD)")
The difference between the consensus estimate and the actual stock price PODD (PODD)
Insulet revolutionized the treatment of type 1 diabetes with the creation of the Omnipod, a tubeless insulin pump (patch). This makes managing the disease much more convenient. This chart shows how much analysts believe they can capture the market from traditional pumps and pens. It shows the gap between the consensus forecast and the current price.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-PODD-PODD&v=1772511645639 "A chart showing the difference between the consensus forecast and the actual stock price. PODD (PODD)")
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
Insulet is an innovator in diabetes treatment, producing wearable insulin pumps (Omnipod) that operate without tubes. This chart shows the general expectations of analysts for the medical device sector. It reflects whether experts believe patients will quickly transition from injections to pumps or whether they see a slowdown in the trend.
Analysts' consensus forecast for the overall market share price
Insulet (PODD) is an innovator in diabetes treatment, known for its Omnipod system, the first tubeless insulin pump. They make patients' lives easier by replacing syringes with wearable technology. This chart reflects the overall risk appetite in the market, demonstrating how much confidence experts have in the economics capable of supporting expensive medical innovations.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index PODD
Insulet Corporation revolutionized the treatment of type 1 diabetes with its Omnipod system—the first tubeless, wearable insulin pump. This device simplifies patients' lives. This graph reflects the rapid transition from traditional injections to smart pump technology. Its dynamics measure the growth rate of new users of their high-margin disposable pods.
AKIMA Market Segment Index - Specialized medical equipment
Insulet is a pioneer in diabetes treatment, creator of the Omnipod, the world's first wireless insulin pump (patch) that replaces traditional injections. This aggregate metric evaluates companies. The chart shows the sector average. This benchmark: how much do Insulet's technological breakthroughs and its razor model (pump and consumables) differentiate it from the average competitor?
The AKIM Index for the overall market
Insulet is an innovator in diabetes treatment, maker of the Omnipod tubeless patch pump. This is a fast-growing MedTech segment, competing with DexCom and Tandem. This chart, reflecting the market average, provides context. It helps assess how this growth story in the protective healthcare sector compares to the overall macroeconomic trends impacting markets.
